What is Clovis Oncology ?

Clovis Oncology is a biopharmaceutical company focused on developing novel, targeted, and immuno-oncology therapies. Its goal is to create innovative drugs that can transform the cancer treatment landscape, providing patients with a better quality of life, longer survival, and fewer treatment-related toxicities.

Clovis Oncology is dedicated to discovering, developing, and commercializing novel cancer therapies to meet the needs of patients and healthcare professionals. Its product pipeline includes targeted and immune therapies for specific cancer types, as well as therapies targeting cancer stem cells.

The company's research and development efforts are primarily focused on the following areas:

1.Targeted Therapies: Developing drugs that target specific mutated genes or proteins in cancer cells, aimed at stopping or inhibiting their growth.

2.Immuno-Oncology Therapies: Activating the patient's own immune system to attack cancer cells, thereby eliminating tumors or preventing their recurrence.

3.Cancer Stem Cell Therapies: Targeting the cancer stem cells that drive tumor growth, aiming to eliminate the root cause of tumorigenesis.

Clovis Oncology is committed to providing patients worldwide with more effective and safer treatment options.